title: Personalized network-based treatments in oncology.
abstract: Network medicine aims at unraveling cell signaling networks to propose personalized treatments for patients suffering from complex diseases. In this short review, we show the relevance of network medicine to cancer treatment by outlining the potential convergence points of the most recent technological and scientific developments in both drug design and signaling network analysis.
authors.affiliation: Cellular Signal Integration Group (C-SIG), Center for Biological Sequence Analysis (CBS), Department of Systems Biology, Technical University of Denmark (DTU), Lyngby, Denmark.
authors.forename: X
authors.initials: X
authors.lastname: Robin
authors.forename: P
authors.initials: P
authors.lastname: Creixell
authors.forename: O
authors.initials: O
authors.lastname: Radetskaya
authors.forename: C C
authors.initials: CC
authors.lastname: Santini
authors.forename: J
authors.initials: J
authors.lastname: Longden
authors.forename: R
authors.initials: R
authors.lastname: Linding
mesh_terms: D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology / Q000627:therapeutic use*; D015415:Biomarkers / Q000378:metabolism; D015195:Drug Design; D006801:Humans; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D057285:Precision Medicine / Q000379:methods*; D060066:Protein Interaction Maps; D011499:Protein Processing, Post-Translational; D015398:Signal Transduction; D049490:Systems Biology
chemical_list: D015415:Biomarkers